Search

everythinglearnresearchcommunity

for

Search:↓

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

Blocking glucocorticoid receptors improves glucose metabolism in a PCOS mouse model.

S5αR inhibitors might help treat schizophrenia and other mental disorders but need more research.

The skin's ability to produce hormones is linked to various skin conditions, and better understanding this process could lead to new treatments.

Eating healthy, exercising, and taking certain supplements can help manage Polycystic Ovary Syndrome symptoms.

Some hair loss and prostate drugs might increase the risk of diabetes and heart disease.

Sex hormones, especially estradiol, can change chicken feather shapes and colors.

The research identified and described a gene important for hormone conversion in endangered catfish, which varies in activity during different reproductive stages and after hormone treatment.

Early diagnosis and individualized treatment improve outcomes for Congenital Adrenal Hyperplasia.

Acne is caused by genetics, diet, hormones, and bacteria, with treatments not yet curative.

Recent genetic insights show that low-renin hypertension includes a range from essential hypertension to secondary or familial forms, affecting diagnosis and treatment.

Consider benefits and risks of new alopecia treatments for safety.

Steroid sulfatase is important for activating hormones that affect memory, brain function, and certain diseases, and could be a target for treating hormone-related disorders.

Women with PCOS have higher 5α-reductase activity, which may be linked to insulin resistance.

Non-invasive methods show promise for diagnosing skin diseases like psoriasis and lupus but need more research for regular use.

Early treatment of PCOS in teens is crucial to prevent long-term health issues like diabetes and heart disease.

5-alpha reductase inhibitors may have additional effects on cancer, mental health, heart health, and hormone levels beyond treating prostate enlargement.

Minoxidil boosts hair growth by opening potassium channels and increasing cell activity.

The update highlights that non-classic congenital adrenal hyperplasia is common in women with excess male hormones, requires specific hormone tests for diagnosis, and has various treatment options depending on age and symptoms.

Hormones significantly affect hair and oil gland function in the skin, and more research is needed on skin-related hormone disorders.

Testosterone may slow down wound healing and increase inflammation.

DHT, a testosterone byproduct, causes male pattern baldness.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

The document suggests creating a validated score to diagnose Cushing's Syndrome and considers plasma steroid profiling as a simpler diagnostic method.

The mineralocorticoid receptor may play a role in skin and hair health and could be a new target for treating related disorders.

Researchers found potential urine markers for polycystic ovary syndrome, including testosterone-glucuronide and 11α-hydroxyprogesterone, which may help diagnose the condition.

Finasteride and dutasteride reduce neurosteroid production, possibly helping treat glioblastoma.

AKR1D1 controls glucocorticoid levels and receptor activity in liver cells.

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.

Understanding hair biology is key to developing better treatments for hair and scalp issues.